CNR2 and breast carcinoma: In the context of the breast cancer cell lines, CB2-based cytotoxicity is a rather unexpected behavior, as the main signal route for it, ceramide biosynthesis, is counterbalanced by the sphingosine-1-phosphate synthesis in this setting [19].